跳至主要内容
临床试验/JPRN-UMIN000030467
JPRN-UMIN000030467已完成未知

Prospective interventional study assessing the effectiveness on ameliorating surgical stress and the enhancement of recovery after surgery by Miyagi Cancer Center Head and Neck ERAS Protocol (MCC-HN ERAS) - ERAS protocol for head and neck cancer at Miyagi Cancer Center (MCC-HN-ERAS)

Miyagi Cancer Center0 个研究点目标入组 60 人开始时间: 2017年12月19日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
60

研究概览

简要总结

The duration of hospital stay: Median 25 days. The duration until completion of the discharge criteria: Median 17 days. Early mobilization: 86.0% (POD1), 96.5% (POD2). Enteral nutrition: 80.1% (POD1), 100% (POD2). Postoperative pain: Mean VAS scores of 1.51 to 3.13. Clavien Dindo grade II or higher postoperative complications: 27.6% of the patients. The mean QOR40 score: 179.6 preoperatively, 146.1 at POD3, and 167.8 at POD7.

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Patients with hypersensitivity to dexamethasone. 2) Patients with active infectious diseases such as tuberculosis, viral infection and mycosis. 3) Patients with thrombosis. 4) Patients with poor-controlled diabetes mellitus; e.g. insulin dependent. 5) Patients with uncontrolled psycogenic disease, such as depression. 6) Patients with active peptic ulcer. 7) Patients with uncontrolled glaucoma. 8) Patients with regular use of oral steroid for such conditions as autoimmune disease.

研究者

相似试验

Prospective interventional study assessing the... | 临床试验